Depletion of the CD10+GPR77+ subset abrogated tumor growth and reversed chemosensitivity, and the effect also replicated with administration of GPR77 neutralizing mAb in a patient-derived xenograft model of breast cancer. This evidence concerns the gene C5AR2 and breast carcinoma.